Remnant cholesterol lowering in cardiovascular disease risk reduction in statin trials: meta-regression analyses

被引：0
|
作者：
Nordestgaard, A. T. [1 ]
Nordestgaard, B. G. [1 ]
机构：
[1] Copenhagen Univ Hosp Herlev & Gentofte, Copenhagen, Denmark
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2816
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
    Lobo, L. M.
    Molinero, G.
    Masson, W.
    Siniawski, D.
    Masson, G.
    Huerin, M.
    Nogueira, J. P.
    Benincasa, F.
    Losada, P.
    Suarez, F.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2981 - 2981
  • [12] Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials
    Bouxsein, Mary L.
    Eastell, Richard
    Liu, Li-Yung
    Wu, Lucy A.
    de Papp, Anne E.
    Grauer, Andreas
    Marin, Fernando
    Cauley, Jane A.
    Bauer, Douglas C.
    Black, Dennis M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 (10) : 1977 - 1978
  • [13] Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression
    Maiorino, Maria Ida
    Longo, Miriam
    Scappaticcio, Lorenzo
    Bellastella, Giuseppe
    Chiodini, Paolo
    Esposito, Katherine
    Giugliano, Dario
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [14] Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression
    Maria Ida Maiorino
    Miriam Longo
    Lorenzo Scappaticcio
    Giuseppe Bellastella
    Paolo Chiodini
    Katherine Esposito
    Dario Giugliano
    Cardiovascular Diabetology, 20
  • [15] Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials
    Thomopoulos, Costas
    Parati, Gianfranco
    Zanchetti, Alberto
    JOURNAL OF HYPERTENSION, 2014, 32 (12) : 2285 - 2295
  • [16] Cardiovascular risk reduction: the future of cholesterol lowering drugs
    Malham, Sarah Bou
    Goldberg, Anne Carol
    CURRENT OPINION IN PHARMACOLOGY, 2016, 27 : 62 - 69
  • [17] Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy
    Kizer, Jorge R.
    Madias, Christopher
    Wilner, Brian
    Vaughan, Carl J.
    Mushlin, Alvin I.
    Trushin, Paula
    Gotto, Antonio M., Jr.
    Pasternak, Richard C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (09): : 1289 - 1296
  • [18] Cardiovascular Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Meta-Regression Analysis of 17 Randomized Trials
    Rodriguez-Valadez, Jose M.
    Hunink, Myriam
    Masharani, Umesh
    Yeboah, Joseph
    Park, Meyeon
    Li, Lihua
    Weber, Ellerie
    Li, Yan
    Berkalieva, Asem
    Max, Wendy
    Fleischmann, Kirsten
    Ferket, Bart
    DIABETES, 2022, 71
  • [19] Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
    Masson, Walter
    Lobo, Martin
    Siniawski, Daniel
    Molinero, Graciela
    Masson, Gerardo
    Huerin, Melina
    Nogueira, Juan Patricio
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [20] Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
    Walter Masson
    Martin Lobo
    Daniel Siniawski
    Graciela Molinero
    Gerardo Masson
    Melina Huerín
    Juan Patricio Nogueira
    Lipids in Health and Disease, 19
12345